Cabigas, Shekinah Sheen .
HRN: 21-49-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 750MG (VIAL)
06/05/2022
06/11/2022
IV
485mg
Q8hrs
Pcap C; R/o DF
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes